Results From the International Drug Coated Balloon Registry for the Treatment of Bifurcations. Can a Bifurcation Be Treated Without Stents?

OBJECTIVES: This observational study assessed the 9-month clinical outcomes in patients with coronary bifurcation lesions suitable for drug-coated balloon (DCB) angioplasty. It was the intention to use DCB's without additional stenting (DCB-only strategy) in selected patients for this chosen strategy. Bail-out main branch (MB) and/or side branch (SB) stenting, however, were permissible when flow limiting dissections or excessive recoil occurred. BACKGROUND: A multitude of interventional strategies have been studied to treat bifurcation lesions. With the availability of DCB angioplasty, investigators have been using this interventional tool with the optional implantation of bare metal stents (BMS). METHODS: This study is an international, prospective, multicenter registry enrolling patients with coronary bifurcation lesions including a side branch ≥2 mm in diameter. Patients with stable angina and documented ischemia or selected forms of unstable angina due to a culprit bifurcation lesion of any Medina classification type were recruited. The primary endpoint was clinically driven target-lesion revascularization (TLR) at 9 months. Secondary endpoints included 9-month major adverse cardiac events (death, myocardial infarction, or TLR), technical success, in-hospital outcomes and vessel thrombosis rates. RESULTS: A total 127 patients 66.1 ± 10.1 years of age were enrolled. Demographic characteristics were 80.3% (102/127) male gender, 31.5% (40/127) diabetes, 91.3% (116/127) hypertension, 7.1% (9/127) ST-elevation myocardial infarction (STEMI), and 9.4% (12/127) non ST-elevation myocardial infarction (NSTEMI). The 130 lesions were treated with 184 DCB's and 64 BMS. In 53.8% (70/130) of all lesions the DCB-only strategy could be used while 34.6% (45/130) of lesions had at least 1 stent (BMS) in the main branch, 8.5% (11/130) had at least 1 stent in the side branch and 3.1% (4/130) needed at least 1 stent in the main and side branch. 94.5% patients (121/127) were available for follow-up after 9.8 ± 2.0 months. The TLR rate was 4.6% in the absence of any thrombotic events in the treated vessels whereas the 9-month MACE rate was 6.2%. CONCLUSION: This observational study suggests that the DCB-only strategy is safe and effective to treat selected bifurcations while benefiting from a shortened dual antiplatelet therapy (DAPT).

Value of intracardiac ultrasound in the diagnosis of arrhythmogenic right ventricular dysplasia-cardiomyopathy.

The value of imaging techniques such as transthoracic echocardiography, angiography and magnetic resonance imaging in the diagnosis of arrhythmogenic right ventricular dysplasia-cardiomyopathy (ARVD) is limited. First experiences with intracardiac ultrasound have been made during electrophysiological interventions. The ability of using intracardiac ultrasound in ARVD should be tested. In 25 patients with IFSC/ESC criteria of ARVD (nine males, 16 females) with a mean age of 54 (29-78) years suffering from sustained ventricular tachycardia in three cases, positive family history in four cases and syncopes in six cases intracardiac ultrasound was done using 6 French (Fr) 12.5 MHz catheters and the CLEAR VIEW ULTRA Intravascular System (Boston Scientific). Images were taken from the right ventricular apex, outflow tract and infundibulum. Results were compared to selective right ventricular angiography. Right ventricular (RV) angiography revealed bulges and a partial or complete loss of trabecular structure in 22 cases at the apex, in 13 cases at the infundibulum and in 14 cases at the right ventricular outflow tract. Intracardiac echocardiography was able to demonstrate sacculations in all patients at the apex, in 20 cases at the infundibulum and in 16 patients at the right ventricular outflow tract. Sacculations in all segments of the right ventricle were based on a partial or complete loss of trabecular structure. A whole of 36 segments presented with wall thinning (<3 mm) and 15 segments with normal wall structure and wall thickening of surrounding myocardium (>4 mm). In 26 segments the structure of right ventricular wall was inhomogeneous. In comparison to angiography as the 'gold standard' intracardiac ultrasound presented with additional details in 12 cases and the demonstration of angiographic misinterpretation in one case. Intracardiac ultrasound in ARVD is feasible in all cases with 6 Fr 12.5 MHz catheters and provides additional information to the angiographic phenomenon of bulges and to the aspect of tissue characterisation.